Phase 1 Alzheimer's Disease Trial, Not Yet Recruiting NCT07458620 Sponsor: Chang Gung Memorial Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 1 Alzheimer's Disease Trial, Not Yet Recruiting

NCT07458620
Not Yet Recruiting Phase 1

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been formally diagnosed with Alzheimer's Disease by both a neurologist and a psychiatrist at the hospital.
  • People whose brain scan (called an Amyloid-PET scan) has come back positive, showing a build-up of amyloid plaques in the brain.
  • People who are willing to sign a consent form, or who have a legal representative willing to sign on their behalf.
  • People who are 18 years of age or older.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are unable to make their own decisions about participation, and where no legal representative or authorised person is available to provide consent on their behalf.
  • People who have previously had surgery involving the neck's lymphatic system, the area at the back of the nose and throat, or the inside of the skull.
  • People who have thyroid disease or chronic heart failure.
  • People who have a history of allergies to shellfish or iodine, as a substance called Indocyanine Green (ICG) — which may trigger reactions in people with these allergies — is used during the procedure.
  • People who have unresolved concerns or questions about the trial that cannot be answered to their satisfaction.
  • People who are considered medically unsuitable for general anaesthesia — for example, those with severe heart or lung problems, or a known allergy to certain anaesthetic medications.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 August 2026

Contact this trial

Phone: +886-975056253

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 1
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 May 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Incidence of Treatment-Emergent Adverse Events (Safety and Feasibility)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov